Identification of FAT3 as a new candidate gene for adolescent idiopathic scoliosis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 07 2022
Historique:
received: 15 02 2022
accepted: 12 07 2022
entrez: 19 7 2022
pubmed: 20 7 2022
medline: 22 7 2022
Statut: epublish

Résumé

In an effort to identify rare alleles associated with adolescent idiopathic scoliosis (AIS) whole-exome sequencing was performed on a discovery cohort of 73 unrelated patients and 70 age-and sex matched controls, all of French-Canadian ancestry. A collapsing gene burden test was performed to analyze rare protein-altering variants using case-control statistics. Since no single gene achieved statistical significance, targeted exon sequencing was performed for 24 genes with the smallest p values, in an independent replication cohort of unrelated severely affected females with AIS and sex-matched controls (N = 96 each). An excess of rare, potentially protein-altering variants was noted in one particular gene, FAT3, although it did not achieve statistical significance. Independently, we sequenced the exomes of all members of a rare multiplex family of three affected sisters and unaffected parents. All three sisters were compound heterozygous for two rare protein-altering variants in FAT3. The parents were single heterozygotes for each variant. The two variants in the family were also present in our discovery cohort. A second validation step was done, using another independent replication cohort of 258 unrelated AIS patients having reach their skeletal maturity and 143 healthy controls to genotype nine FAT3 gene variants, including the two variants previously identified in the multiplex family: p.L517S (rs139595720) and p.L4544F (rs187159256). Interestingly, two FAT3 variants, rs139595720 (genotype A/G) and rs80293525 (genotype C/T), were enriched in severe scoliosis cases (4.5% and 2.7% respectively) compared to milder cases (1.4% and 0.7%) and healthy controls (1.6% and 0.8%). Our results implicate FAT3 as a new candidate gene in the etiology of AIS.

Identifiants

pubmed: 35853984
doi: 10.1038/s41598-022-16620-6
pii: 10.1038/s41598-022-16620-6
pmc: PMC9296578
doi:

Substances chimiques

Cadherins 0
FAT3 protein, human 0
Epidermal Growth Factor 62229-50-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12298

Informations de copyright

© 2022. The Author(s).

Références

Neuron. 2011 Sep 8;71(5):820-32
pubmed: 21903076
Nat Rev Dis Primers. 2015 Sep 24;1:15030
pubmed: 27188385
Eur Spine J. 2012 Oct;21(10):1905-19
pubmed: 22695700
Hum Mol Genet. 2016 Jan 1;25(1):202-9
pubmed: 26566670
Sci Rep. 2015 Nov 12;5:16473
pubmed: 26559152
Med Res Rev. 2014 Jan;34(1):190-221
pubmed: 23720094
Am J Hum Genet. 2008 Sep;83(3):311-21
pubmed: 18691683
Dev Dyn. 2005 Nov;234(3):747-55
pubmed: 16059920
Spine (Phila Pa 1976). 2006 Jul 15;31(16):1815-9
pubmed: 16845357
PLoS Genet. 2014 Oct 23;10(10):e1004726
pubmed: 25340762
Sci Rep. 2015 Mar 06;5:8829
pubmed: 25743105
Blood. 2013 Jun 6;121(23):4749-52
pubmed: 23603912
Nat Rev Dis Primers. 2015 Nov 19;1:15071
pubmed: 27189754
Science. 2007 Jan 26;315(5811):525-8
pubmed: 17185560
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
J Bone Joint Surg Br. 1968 Feb;50(1):24-30
pubmed: 5641594
Science. 2006 Dec 22;314(5807):1930-3
pubmed: 17185601
J Clin Invest. 2015 Mar 2;125(3):1124-8
pubmed: 25642776
Am J Med Genet A. 2010 May;152A(5):1178-88
pubmed: 20425822
J Med Genet. 2008 Feb;45(2):87-92
pubmed: 17932119
Scoliosis. 2006 Mar 31;1(1):2
pubmed: 16759428
Curr Opin Cardiol. 2012 May;27(3):197-201
pubmed: 22450721
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
G3 (Bethesda). 2014 Dec 12;5(2):167-74
pubmed: 25504735
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1193-8
pubmed: 22223662
Am J Hum Genet. 2015 Aug 6;97(2):337-42
pubmed: 26211971
Community Genet. 2007;10(3):147-58
pubmed: 17575459
Spine (Phila Pa 1976). 2000 Sep 15;25(18):2372-80
pubmed: 10984791
Nat Commun. 2015 Mar 18;6:6452
pubmed: 25784220
Am J Med Genet. 1997 Feb 11;68(4):386-90
pubmed: 9021007
Hum Mol Genet. 2014 Oct 1;23(19):5271-82
pubmed: 24833718
Pain Physician. 2015 Sep-Oct;18(5):419-31
pubmed: 26431121
J Med Genet. 2016 Jul;53(7):488-93
pubmed: 26989089
Nat Rev Genet. 2002 Apr;3(4):285-98
pubmed: 11967553
J Med Genet. 1999 Jun;36(6):485-9
pubmed: 10874640
Hum Mol Genet. 2011 Apr 1;20(7):1456-66
pubmed: 21216876
Nat Genet. 2014 May;46(5):467-73
pubmed: 24686850
Genome Med. 2009;1(11):24
pubmed: 21542888
Nat Commun. 2014 Sep 03;5:4777
pubmed: 25182715
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Spine (Phila Pa 1976). 1997 Sep 1;22(17):2009-14; discussion 2015
pubmed: 9306532
Int J Epidemiol. 2013 Oct;42(5):1285-99
pubmed: 23071140
Nat Genet. 2011 Oct 23;43(12):1237-40
pubmed: 22019779
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Nat Genet. 2013 Jun;45(6):676-9
pubmed: 23666238
Int J Mol Med. 2006 Sep;18(3):523-8
pubmed: 16865240
Development. 2012 May;139(10):1806-20
pubmed: 22510986
Eur J Hum Genet. 2011 Aug;19(8):865-9
pubmed: 21407261

Auteurs

Dina Nada (D)

Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Sainte-Justine University Hospital Research Center, (room 2.17.027), 3175 Chemin de la Côte-Ste-Catherine, Montreal, QC, H3T 1C5, Canada.
Pharmacology and Biochemistry Department, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt.

Cédric Julien (C)

Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Sainte-Justine University Hospital Research Center, (room 2.17.027), 3175 Chemin de la Côte-Ste-Catherine, Montreal, QC, H3T 1C5, Canada.
Injury Repair Recovery Program, McGill University Health Center Research Institute, Montreal, QC, Canada.

Simon Papillon-Cavanagh (S)

Department of Human Genetics, McGill University, Montreal, QC, Canada.

Jacek Majewski (J)

Department of Human Genetics, McGill University, Montreal, QC, Canada.

Mohamed Elbakry (M)

Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Sainte-Justine University Hospital Research Center, (room 2.17.027), 3175 Chemin de la Côte-Ste-Catherine, Montreal, QC, H3T 1C5, Canada.
Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.

Wesam Elremaly (W)

Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Sainte-Justine University Hospital Research Center, (room 2.17.027), 3175 Chemin de la Côte-Ste-Catherine, Montreal, QC, H3T 1C5, Canada.
Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.

Mark E Samuels (ME)

Sainte-Justine University Hospital Research Center, Montreal, QC, Canada.
Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.

Alain Moreau (A)

Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Sainte-Justine University Hospital Research Center, (room 2.17.027), 3175 Chemin de la Côte-Ste-Catherine, Montreal, QC, H3T 1C5, Canada. alain.moreau.hsj@ssss.gouv.qc.ca.
Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada. alain.moreau.hsj@ssss.gouv.qc.ca.
Department of Stomatology, Faculty of Dentistry, Université de Montréal, Montreal, QC, Canada. alain.moreau.hsj@ssss.gouv.qc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH